https://doi.org/10.4081/reumatismo.2006.94

Biologics targeted at TNF: design, production and challenges

Vol. 58 No. 2 (2006)
Abstract Views: 1678
PDF: 2408
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

B. Gatto
office@pagepress.org
Autoimmune diseases affect millions of people worldwide and, with more than 70 distinct types of pathologies associated with autoimmune processes, represent a wide and fast-moving area of research and clinical interest (1). Extensive preclinical research has focused on the regulation of cytokine expression with special interest in rheumatoid arthritis (RA), and this multidisciplinary effort has contributed to elucidate the roles of cytokines in this and other disabling autoimmune diseases. Tumor necrosis factor alpha (TNFa) emerged from these studies as a pivotal regulator of expression of other pro-inflammatory cytokines such as Interleukin-1 (IL-1) and Interleukin-6 (IL- 6) (2), thus becoming a key target for therapeutic intervention in a redundant cytokine environment...

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

How to Cite

Gatto, B. (2006). Biologics targeted at TNF: design, production and challenges. Reumatismo, 58(2), 94–103. https://doi.org/10.4081/reumatismo.2006.94

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.